Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamar Peretz

Showing results (41-50 of 217) with videos related to

Pageof 22
Sort By:
Cancer Research|August 30, 2018
Clinical Proteomics of Breast Cancer Reveals a Novel Layer of Breast Cancer ClassificationGali Yanovich, Hadar Agmon, Michal Harel, et al.
Blood|December 31, 2005
Role of endothelial heparanase in delayed-type hypersensitivityEvgeny Edovitsky, Immanuel Lerner, Eyal Zcharia, et al.
Harefuah|February 3, 2006
[Prophylactic oophorectomy among carriers of BRCA1/2 mutations--demographic and pathologic data]Hagit Daum, Michal Sagi, Eli Pikarsky, et al.
Medical Oncology (Northwood, London, England)|December 21, 2012
Hypertension as a predictive biomarker in bevacizumab treatment for colorectal cancer patientsEsther Tahover, Beatrice Uziely, Azzam Salah, et al.
Cancer|July 13, 2002
Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinomaBenjamin Nisman, Vivian Barak, Amos Shapiro, et al.
Harefuah|December 23, 2006
[The prognostic value of CA 19-9 in the preoperative work-up of pancreatic cancer patients]Ronit Grinbaum, Aviram Nissan, Nahum Beglaibter, et al.
Cancer Genetics and Cytogenetics|April 18, 2003
Cytogenetic analysis of melanoma cell lines: subclone selection in long-term melanoma cell culturesMichal Lotem, Orly Yehuda-Gafni, Eliza Butnaryu, et al.
Oncology|March 24, 2012
The clinical effect of the inhibitor of apopotosis protein livin in melanomaItay Lazar, Riki Perlman, Michal Lotem, et al.
Frontiers in Cell and Developmental Biology|December 22, 2022
Metabolomic profiling of triple negative breast cancer cells suggests that valproic acid can enhance the anticancer effect of cisplatinAvital Granit, Kumudesh Mishra, Dinorah Barasch, et al.
Tumori|March 10, 2010
Mitomycin C and vinblastine: an active regimen in previously treated breast cancer patientsInna Ospovat, Nava Siegelmann-Danieli, Tal Grenader, et al.
Pageof 22

Showing results (41-50 of 217) with videos related to

Sort By:
Pageof 22
Cancer Research|August 30, 2018
Clinical Proteomics of Breast Cancer Reveals a Novel Layer of Breast Cancer ClassificationGali Yanovich, Hadar Agmon, Michal Harel, et al.
Blood|December 31, 2005
Role of endothelial heparanase in delayed-type hypersensitivityEvgeny Edovitsky, Immanuel Lerner, Eyal Zcharia, et al.
Harefuah|February 3, 2006
[Prophylactic oophorectomy among carriers of BRCA1/2 mutations--demographic and pathologic data]Hagit Daum, Michal Sagi, Eli Pikarsky, et al.
Medical Oncology (Northwood, London, England)|December 21, 2012
Hypertension as a predictive biomarker in bevacizumab treatment for colorectal cancer patientsEsther Tahover, Beatrice Uziely, Azzam Salah, et al.
Cancer|July 13, 2002
Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinomaBenjamin Nisman, Vivian Barak, Amos Shapiro, et al.
Harefuah|December 23, 2006
[The prognostic value of CA 19-9 in the preoperative work-up of pancreatic cancer patients]Ronit Grinbaum, Aviram Nissan, Nahum Beglaibter, et al.
Cancer Genetics and Cytogenetics|April 18, 2003
Cytogenetic analysis of melanoma cell lines: subclone selection in long-term melanoma cell culturesMichal Lotem, Orly Yehuda-Gafni, Eliza Butnaryu, et al.
Oncology|March 24, 2012
The clinical effect of the inhibitor of apopotosis protein livin in melanomaItay Lazar, Riki Perlman, Michal Lotem, et al.
Frontiers in Cell and Developmental Biology|December 22, 2022
Metabolomic profiling of triple negative breast cancer cells suggests that valproic acid can enhance the anticancer effect of cisplatinAvital Granit, Kumudesh Mishra, Dinorah Barasch, et al.
Tumori|March 10, 2010
Mitomycin C and vinblastine: an active regimen in previously treated breast cancer patientsInna Ospovat, Nava Siegelmann-Danieli, Tal Grenader, et al.
Pageof 22